Evidence map›Paper›PMID 34910591›Full record

ReviewEcoSal Plus2021

Suppressor Mutants: History and Today's Applications.

David E Bautista, Joseph F Carr, Angela M Mitchell

Abstract readReview
In one paragraph

Review in EcoSal Plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Effects of pleiotropicJournal of bacteriology · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David E Bautista *Department of Biology, Texas A&M University, College Station, Texas, USA.
Joseph F Carr *Department of Biology, Texas A&M University, College Station, Texas, USA.
Angela M MitchellDepartment of Biology, Texas A&M University, College Station, Texas, USA.ORCID 0000-0003-1062-0716

Funding

Biogenesis of cyclic and phospholipid-linked enterobacterial common antigenR01AI155915 · NIAID · TEXAS A&M UNIVERSITY · PI MITCHELL, ANGELA MARIE · 2021 to 2025
$2.0M
NIAID NIH HHS R01 AI155915
6 · The paper itself

Abstract

For decades, biologist have exploited the near boundless advantages that molecular and genetic tools and analysis provide for our ability to understand biological systems. One of these genetic tools, suppressor analysis, has proven invaluable in furthering our understanding of biological processes and pathways and in discovering unknown interactions between genes and gene products. The power of suppressor analysis lies in its ability to discover genetic interactions in an unbiased manner, often leading to surprising discoveries. With advancements in technology, high-throughput approaches have aided in large-scale identification of suppressors and have helped provide insight into the core functional mechanisms through which suppressors act. In this review, we examine some of the fundamental discoveries that have been made possible through analysis of suppressor mutations. In addition, we cover the different types of suppressor mutants that can be isolated and the biological insights afforded by each type. Moreover, we provide considerations for the design of experiments to isolate suppressor mutants and for strategies to identify intergenic suppressor mutations. Finally, we provide guidance and example protocols for the isolation and mapping of suppressor mutants.

Indexed as

Epistasis, GeneticSuppression, Geneticbacterial geneticsgenetic mappingscreeningselectionsuppressor mutant

Identifiers

PMID34910591
PMCPMC9008745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.